11 |
Glycoprotein M and ESCRT in herpes simplex virus type 1 assemblyRen, Yudan January 2012 (has links)
Herpes simplex virus type 1 (HSV-1) has a large linear double-stranded DNA genome in an icosahedral capsid shell, a cell-derived lipid envelope and a proteinaceous tegument layer. There are over fifty viral proteins and many host proteins identified in HSV-1 virions. The final formation of mature virus particles requires the membrane wrapping of tegumented capsids in the cytoplasm, a process termed secondary envelopment. This process involves the coordination of numerous viral and cellular proteins and results in double-membrane structures with enveloped virions contained within cellular vesicles. Mature viruses are then released through the fusion of these virion-containing vesicles and plasma membranes. This thesis describes investigation into the functions of viral glycoprotein M (gM) and the cellular Endosomal Sorting Complexes Required for Transport (ESCRT) in secondary envelopment. Firstly, it has been reported that gH/L can be efficiently internalised and targeted to the TGN by the co-expression of gM in transfection assays. In order to examine the role of gM in guiding the localisation of viral proteins in infected cells, a HSV-1 gM deletion virus (∆gM), and its revertant virus were constructed. The major phenotype demonstrated was that the absence of gM caused the internalisation of cell surface gH/L to be inhibited and higher levels of gH/L to be observed on the cell surface. Further, lower levels of gH/L were detected in purified ∆gM virions, which was in agreement with the delayed entry kinetics, smaller plaque sizes and greater replication deficits at low multiplicity of infection observed in ∆gM infected cells. Over all the results presented in this thesis demonstrate that in infected cells the efficient incorporation of gH/L into virions relies on the function of gM in HSV-1. Secondly, during HSV-1 secondary envelopment the budding and scission of the viral envelope from the host membrane share topological similarities with the formation of intraluminal vesicle in multivesicular bodies, retrovirus budding, and abscission at the end of cytokinesis, processes that require the cellular ESCRT machinery. There are four multiprotein ESCRT complexes and many associated proteins involved in their regulation. It has been previously shown that the ESCRT-III complex and a functional ATPase VPS4 are required for HSV-1 secondary envelopment, but different from the strategy utilised by HIV-1, the recruitment of ESCRT during HSV-1 infection is independent of TSG101 and/or ALIX. Data presented in this thesis demonstrate that CHMP4A/B/C proteins of the ESCRT-III complex are specifically crucial for HSV-1 secondary envelopment. Simultaneous depletion of CHMP4A/B/C proteins significantly inhibited HSV-1 replication. Ultrastructure analysis revealed that there were virtually no extracellular virions in CHMP4A/B/C depleted samples while more free capsids were observed in the cytoplasm, although the nuclear capsids and primary envelopment events appeared to be normal. In order to identify interactions between HSV-1 and ESCRT proteins, 22 HSV-1 tegument proteins were cloned and tested against a panel of ESCRT and ESCRT-associated proteins in yeast two-hydrid assays. Analysis of positive hits from yeast two-hybrid interaction screens using GST pull-down, co-immunoprecipitation and protein co-localisation assays have validated interactions of pUL47 with CC2D1A/1B, CIN85, CHMP6 and ALIX, pUL46 and pUL49 with CC2D1A/1B and CIN85, and pUL16 with CC2D1A/1B. Furthermore, the newly identified ESCRT associated proteins CC2D1A and CC2D1B have been detected in purified virions. The role of the identified ESCRT proteins in HSV-1 replication has been investigated using siRNA depletion. Unfortunately siRNA depletions of the various ESCRT candidates individually or in combinations did not show any significant effect on HSV-1 replication. Overall these data suggest that unlike HIV and other retroviruses, HSV-1 has evolved multiple parallel pathways to hijack the ESCRT machinery to facilitate its replication, particularly, through the interactions that lead directly to the recruitment of CHMP4A/B/C proteins. Disruption of some of these pathways did not prevent HSV-1 replication in tissue culture, suggesting any one potential pathway is sufficient for ESCRT recruitment to sites of HSV-1 assembly.
|
12 |
Determining the Effect of HSP90 Inhibitor Geldanamycin on Herpes Simplex Virus Type-1 Production in Infected Vero CellsScherer, Brooklynn M. 30 April 2019 (has links)
No description available.
|
13 |
The role of poly(C)-binding protein 1 in HSV-1 InfectionThornbury, Mackenzie 11 1900 (has links)
Lors de l'infection par le virus herpès simplex de type 1 (VHS-1), quatre types de capsides nucléaires sont créés : les procapsides et les capsides A, B, et C. Sur les quatre capsides, seules les capsides C contiennent de l'ADN viral et deviendront des particules infectieuses. Un niveau de régulation se produit lors de la sortie du noyau qui favorise la sortie d’es capsides C du noyau. Le mécanisme qui sous-tend ce phénomène est actuellement inconnu. Les recherches actuelles suggèrent que l'interaction entre la protéine virale pUL25 modifie la conformation de la couche hexamérique plane du complexe de sortie nucléaire (NEC) pour y introduire des pentamères et donc causer un arrondissement de la membrane et le bourgeonnement des capsides. Cependant, des questions subsistent quant à la manière dont les capsides A, B et C sont différenciées au sein du noyau pour assurer une sortie spécifique de la capside C puisque pUL25 se retrouve dans tous les types de capsides. Nous étudions ici comment les protéines de l'hôte peuvent agir dans la sortie nucléaire des capsides C. En se basant sur une étude précédente du laboratoire où la protéine hôte poly(C)-binding protein 1 (PCBP1) a été trouvée spécifiquement sur les capsides C par spectrométrie de masse, nous explorons le rôle de la PCBP1 dans l'infection par le VHS-1. À l'aide d’essaies de plaques, nous montrons que la PCBP1 est importante pour l'infection virale, car en son absence, les titres diminuent et lorsque la PCBP1 est sur-exprimée, les titres augmentent. Ce résultat ne semble pas être dû au fait que les PCBP1 affectent l'expression génique de sous-ensembles de gènes viraux immédiats précoces, précoces ou tardifs, ni qu'ils affectent la réplication du génome ou son encapsidation. La réduction des PCBP1 ne provoque pas d'accumulation de capsides ou de particules matures tel qu’évalué par la microscopie électronique, mais elle augmente le nombre de capsides B enveloppées dans l'espace périnucléaire (PNS). L'inhibition de PCBP1 diminue également le niveau de protéine pUL24, une protéine virale importante pour la sortie du virus du noyau. Nos résultats démontrent que la PCBP1 pourrait réguler l’activité de pUL24, de sorte que lorsque la PCBP1 est épuisée, pUL24 permet à plus de capsides B de se rendre dans l'espace périnucléaire. Cette recherche constitue un point de départ pour une analyse plus approfondie du mécanisme exact des PCBP1 dans les infections à HSV-1. En outre, elle pourrait fournir des indices importants pour élucider comment le pUL24 favorise la sortie du nucléaire. / During herpes simplex virus type 1 (HSV-1) infection, four types of nuclear capsids are made: procapsids and A-, B- and C-capsids. Of the four capsids, only C-capsids contain the viral DNA and will become infectious progeny. A level of regulation occurs during nuclear egress that ensures only C-capsids exit the nucleus. The mechanism that underlies this phenomenon is presently unknown. Current research suggests the viral protein pUL25 alters the conformation of the viral nuclear egress complex (NEC) that forms a flat hexameric coat on nuclear membranes by the introduction of pentamers and therefore the induction of membrane rounding and viral budding. However, questions remain for how A-, B-, and C-capsids are differentiated within the nucleus to ensure C-capsid specific egress since pUL25 is found on all capsid types. Here we investigate how host proteins may play a role in nuclear egress of C-capsids. Based on the lab’s previous study where host protein poly(C)-binding protein 1 (PCBP1) was found specifically on C-capsids via mass spectrometry, we explore the role of PCBP1 in HSV-1 infection. Using plaque assays we show that PCBP-1 is important for viral infection, as in its absence titers decrease and when PCBP1 is over expressed titers increase. This result does not seem to be due to PCBP1 affecting gene expression of immediate early, early, or late viral gene subsets, nor does it seem to affect genome replication or encapsidation. PCBP1 knockdown does not cause an accumulation of capsids or mature particles as assessed by electron microscopy, but it does increase the number of enveloped B-capsids observed in the perinuclear space (PNS). Depletion of PCBP1 also decreases the level of pUL24, a viral protein implicated in viral nuclear egress. Our results suggest that PCBP1 could be regulating pUL24 for proper activity in nuclear egress, such that when PCBP1 is depleted, more B-capsids are able to bud through the PNS. This research constitutes a starting point for further analysis into the exact mechanism of PCBP1 in HSV-1 infections. In addition, it may provide important clues to elucidate how pUL24 supports nuclear egress.
|
14 |
Rôles d’ITM2B et gM pour le VHS-1 et détermination d’une technique de perméabilisation cellulaireSandolache, Alisa Elena 07 1900 (has links)
Le virus herpès simplex de type I (VHS-1) est présent chez environ 67 % de la population âgée de 50 ans et moins, provoquant des feux sauvages et pouvant causer l’encéphalite chez les nouveaux nés. De plus, plusieurs études suggèrent l’existence d’un lien entre le VHS-1 et la maladie neurodégénérative de l’Alzheimer, caractérisée par la formation de plaques amyloïdes. La protéine ITM2B est considérée protectrice contre la formation de ces plaques, et nous avons déterminé préalablement qu’ITM2B interagirait avec les glycoprotéines virale gM et pUL25, jouant un rôle dans l’encapsidation virale. Nous avons cherché à confirmer cette interaction et déterminer le rôle du complexe gM-ITM2B-pUL25 en observant la production de capsides ainsi que l’encapsidation d’ADN virale en absence de gM. Bien que nos résultats suggèrent que gM n’a pas d’impact sur l’encapsidation, il n’a pas été possible de conclure quant à la production de capsides, faute d’une technique optimisée. Nos analyses par coimmunoprécipitation ont révélé que pUL25 interagirait de façon reproductible avec ITM2B, mais que son interaction avec gM semble faible. Afin de mieux comprendre comment gM est ciblée au noyaux, où pUL25 agit vraisemblablement, nous avons parallèlement exploré une technique de perméabilisation cellulaire spécifique à la membrane plasmique en utilisant la toxine bactérienne de la streptolysine O ainsi que le détergent de la saponine. Nos résultats indiquent que la saponine est le candidat le plus prometteur pour répondre à nos besoins, à condition de déterminer une concentration qui n'impacte pas la morphologie du noyau. / Herpes simplex virus type I (HSV-1) is present in approximately 67 % of the population aged 50
and younger. It causes cold sores, particularly on the lips, but can also cause more serious illnesses such
as encephalitis in newborns. It has also been determined that a link exists between HSV-1 and
Alzheimer’s disease. This neurodegenerative disease is characterized by the formation of amyloid
plaques in the neuronal environment, and the cellular protein ITM2B is considered protective against the
formation of these plaques. Previously, our laboratory preliminarily determined that ITM2B seemingly
interact with the viral glycoprotein gM as well as pUL25, playing a role in viral encapsidation. We sought
to demonstrate this interaction and determine the role of the gM-ITM2B-pUL25 complex by observing
the production of viral capsids as well as the impact on viral DNA encapsidation in the absence of gM.
We thus concluded that gM has no impact on encapsidation, but at this point is unfortunately impossible
to conclude regarding the production of capsids. We determined by co-immunoprecipitation that pUL25
reproducibly interacts with ITM2B, while its interaction with gM is not yet demonstrated. To understand
how gM is targeted to the nucleus, where pUL25 presumably acts, we developed in parallel a reversible
cell permeabilization technique specific to the plasma membrane, using the bacterial toxin streptolysin
O as well as the detergent saponin. We conclude that the most promising candidate for our needs would
be saponin, provided a concentration is established that does not impact the nucleus morphology.
|
15 |
Analysis of artificial chromosomes in human embryonic stem cellsMandegar, Mohammad Ali January 2011 (has links)
The development of safe and efficient gene delivery systems in pluripotent human embryonic stem cells (hESc) is essential to realising their full potential for basic and clinical research. The purpose of this study was to develop an efficient, non-integrating gene expression system in pluripotent hESc using human artificial chromosomes (HAC). Similar to endogenous chromosomes, HAC are capable of gene expression, replication and segregation during cell division. Unlike retroviral-mediated gene delivery vectors, HAC do not integrate into the host genome and can encompass large genomic regions for the delivery of multiple genes. Despite the advantages HAC offer, their use has been limited due to laborious cloning procedures and poor transfection efficiencies, and thus only studied in immortalised and tumour-derived human cell lines. In this study, the high transduction efficiency of herpes simplex virus type-1 (HSV-1) amplicons was utilised to overcome the described difficulties and delivered HAC vectors into pluripotent hESc. Analysis of stable hESc clones showed that de novo gene-expressing HAC were present at high frequencies ranging from 10-70% of metaphases analysed, without integrating into the genome. The established HAC contained an active centromere, and were stably maintained without integration or loss in the absence of selection for 90 days. Stable HAC-containing hESc clones retained their pluripotency as demonstrated by neuronal differentiation, in vitro germ layer and teratoma formation assays. HAC gene expression persisted, with some variation, post-differentiation in the various deriving cell types. This is the first report of successful de novo HAC formation in hESc for gene expression studies. These findings show potential for delivering high-capacity genomic constructs safely and efficiently into pluripotent cells for the purpose of genetic manipulation and ultimately patient-specific somatic gene therapy.
|
16 |
Contribution de la Glycoprotéine M dans la Sortie de HSV-1Zhang, Jie 06 1900 (has links)
Le Virus Herpès Simplex de type 1 (HSV-1) est un agent infectieux qui cause
l’herpès chez une grande proportion de la population mondiale. L’herpès est généralement
considéré comme une maladie bénigne dont la forme la plus commune est l'herpès labial
(communément appelé « bouton de fièvre »), mais elle peut se révéler très sérieuse et causer
la cécité et l’encéphalite, voir létale dans certain cas. Le virus persiste toute la vie dans le
corps de son hôte. Jusqu'à présent, aucun traitement ne peut éliminer le virus et aucun
vaccin n’a été prouvé efficace pour contrôler l’infection herpétique.
HSV-1 est un virus avec un génome d’ADN bicaténaire contenu dans une capside
icosaèdrale entourée d’une enveloppe lipidique. Treize glycoprotéines virales se trouvent
dans cette enveloppe et sont connues ou supposées jouer des rôles distincts dans différentes
étapes du cycle de réplication viral, incluant l'attachement, l'entrée, l’assemblage, et la
propagation des virus. La glycoprotéine M (gM) qui figure parmi ces glycoprotéines
d’enveloppe, est la seule glycoprotéine non essentielle mais est conservée dans toute la
famille herpesviridae. Récemment, l’homologue de gM dans le Pseudorabies virus (PRV),
un autre herpesvirus, a été impliqué dans la phase finale de l’assemblage (i.e.
l’enveloppement cytoplasmique) au niveau du réseau trans-Golgi (TGN) en reconnaissant
spécifiquement des protéines tégumentaires et d’autres glycoprotéines d’enveloppe ([1]).
Toutefois, il a été proposé que cette hypothèse ne s’applique pas pour le HSV-1 ([2]). De
plus, contrairement à la localisation au TGN dans les cellules transfectées, HSV-1 gM se
localise dans la membrane nucléaire et sur les virions périnucléaires durant une infection.
L’objectif du projet présenté ici était d’éclaircir la relation de la localisation et la
fonction de HSV-1 gM dans le contexte d’une infection. Dans les résultats rapportés ici,
nous décrivons tout abord un mécanisme spécifique de ciblage nucléaire de HSV-1 gM. En
phase précoce d’une infection, gM est ciblée à la membrane nucléaire d'une manière virus
ii
dépendante. Cela se produit avant la réorganisation du TGN normalement induite par
l’infection et avant que gM n’entre dans la voie de sécrétion. Ce ciblage nucléaire actif et
spécifique de gM ne semble pas dépendre des plusieurs des partenaires d’interaction
proposés dans la littérature. Ces données suggèrent que la forme nucléaire de gM pourrait
avoir un nouveau rôle indépendant de l’enveloppement final dans le cytoplasme. Dans la
deuxième partie du travail présenté ici, nous avons concentré nos efforts sur le rôle de gM
dans l’assemblage du virus en phase tardive de l’infection et en identifiant un domaine
critique de gM. Nos résultats mettent en valeur l’importance du domaine carboxyl-terminal
cytoplasmique de gM dans le transport de gM du réticulum endoplasmique (RE) à
l’appareil de Golgi, dans l’enveloppement cytoplasmique et la propagation intercellulaire du
virus. Ainsi, l’export du RE de gM a été complètement compromis dans les cellules
transfectées exprimant un mutant de gM dépourvu de sa région C-terminale. La délétion la
queue cytoplasmique de gM cause une réduction légère du titre viral et de la taille des
plaques. L'analyse de ces mutants par microscopie électronique a démontré une
accumulation des nucléocapsides sans enveloppe dans le cytoplasme par rapport aux virus
de type sauvage. Étrangement, ce phénotype était apparent dans les cellules BHK mais
absent dans les cellules 143B, suggérant que la fonction de gM dépende du type cellulaire.
Finalement, le criblage de partenaires d’interaction du domaine C-terminal de gM identifiés
par le système de double-hybride nous a permis de proposer plusieurs candidats
susceptibles de réguler la fonction de gM dans la morphogénèse et la propagation de virus. / Herpes Simplex Virus type 1 (HSV-1) is an infectious agent causing herpes, which
affects a large population worldwide. Herpes is generally considered a benign disease
whose most common form is oral herpes (commonly called "cold sores"), but it can be very
serious and cause herpetic blindness and encephalitis, and even be lethal in some cases. The
virus can persist throughout life in the body of its host. So far, no treatment can eliminate
the virus and no vaccine has proven effective in controlling herpes infections.
HSV-1 has a double-stranded DNA genome embedded in an icosahedral capsid
surrounded by a lipid envelope. Thirteen viral glycoproteins are located in the envelope and
are known or believed to play different roles in different stages of the viral replication cycle,
including attachment, entry, assembly, and viral propagation. Among these envelope
glycoproteins, glycoprotein M (gM) is the only nonessential glycoprotein but is conserved
in all the herpesviridae family. Recently, the homologue of gM in Pseudorabies virus
(PRV), another herpesvirus, has been implicated in the final phase of assembly (e.g. the
cytoplasmic envelopment) at the trans-Golgi network (TGN) ([1]). However, it was
suggested that this does not apply to HSV-1 ([2]). Moreover, unlike its TGN localization in
transfected cells, HSV-1 gM localizes to the nuclear membrane and on the perinuclear
virions during infection.
The objective of the project presented here was to clarify the relationship of the
location and function of HSV-1 gM in the context of an infection. In the results reported
here, we first describe a specific and active mechanism of nuclear targeting of HSV-1 gM. In
early phase of infection, gM is targeted to the nuclear membrane in a virus dependent
manner. This occurs before the known reorganization of the TGN induced by the virus and
before gM enters the secretory pathway. This active and specific nuclear targeting of gM
seemingly does not depend on the functional interaction partners proposed in the literature.
These data suggest that nuclear gM could have a new role independent of that in the final
envelopment in the cytoplasm. In the second part of the work presented here, we focused
iv
our efforts on the role of gM in virus assembly in the late phase of infection and define an
important functional domain within gM. Our results highlight the importance of the
carboxyl-terminal domain of gM in the intracellular transport of gM from endoplasmic
reticulum (ER) to Golgi apparatus, in the cytoplasmic envelopment of the capsids and the
intercellular spread of the virus. Hence, gM ER export was completely compromised in
transfected cells after deletion of its C-terminal tail. Deletion of the gM cytoplasmic tail in
mutant viruses resulted in a slight reduction in viral titer and plaque size. The analysis of
these mutants by electron microscopy showed an accumulation of nucleocapsids without
envelope in the cytoplasm compared to wild-type virus. Interestingly, this phenotype is
apparent in BHK cells but not in 143B cells, hinting that the importance of gM may be cell
type specific. Finally, screening of interaction partners of C-terminal domain of gM
identified by the two-hybrid system allowed us to propose several interesting candidates
that may regulate the function of gM in the virus morphogenesis and propagation.
|
17 |
Atividade da proteína quinase dependente de RNA (PKR) no sistema nociceptivo em um modelo experimental de neuropatia periférica de origem viral / Double stranded RNA-activated protein kinase (PKR) activity in the nociceptive system in an experimental model of peripheral neuropathy of viral originMota, Clarissa Maria Dias 25 February 2016 (has links)
A proteína quinase dependente de RNA (PKR) é uma molécula sentinela ativada em situações de estresse celular, incluindo infecções virais. A ativação de PKR por meio de sua fosforilação aciona cascatas de sinalização intracelular envolvidas em respostas inflamatórias e inibição da síntese protéica. Dados prévios do nosso laboratório sugerem que PKR está envolvida na hiperalgesia térmica de origem inflamatória. No presente estudo, foi investigado o papel da PKR na hiperalgesia térmica induzida pelo vírus da herpes simples tipo 1 (HSV1), durante as fases herpética e pós-herpética, combinando métodos comportamentais, genéticos, farmacológicos e moleculares. Camundongos C57bl/6, PKR+/+ e PKR-/- machos foram inoculados com HSV1. Os grupos controle foram inoculados com HSV1 inativo. Alodínia mecânica e hiperalgesia térmica foram monitoradas antes da inoculação do vírus e 8, 14, 21 e 28 dias após a inoculação. A curva dose e temporesposta e o teste da capsaicina foram realizados no 8º e 21º dias após a inoculação do vírus. Também nos períodos herpético e pós-herpético, foi investigado o perfil de expressão de proteínas envolvidas nas vias de sinalização de PKR (PKR, eIF2?, PACT, IKK e PP2A?), assim como o efeito da inibição de PKR pelo monitoramento da fosforilação de PKR, IKK?/?, P38, JNK, ERK1,2 e STAT3, e expressão de CaMKII? e TRPV1 nos GRD (L3-L6) ipsilateralmente à pata inoculada. Alodínia mecânica e hiperalgesia térmica ficaram evidentes até 28 dias após a inoculação. Camundongos PKR-/- desenvolveram alodínia mecânica, mas não hiperalgesia térmica, quando comparados com animais PKR+/+. A inibição sistêmica de PKR reverteu a hiperalgesia térmica de modo tempo- e dose-dependente e preveniu o comportamento nocifensivo induzido por capsaicina, enquanto PKR-/- apresentaram resposta nocifensiva praticamente ausente em ambas as fases herpética e pósherpética. Houve aumento da expressão de PP2A? e da fosforilação de PKR, IKK?/? e eIF2?, durante os períodos herpético e pós-herpético, e de PACT na fase pósherpética. A inibição de PKR promoveu o aumento da fosforilação de P38 em ambas as fases, e redução da fosforilação de PLC?1 acompanhada do retorno da fosforilação de Akt e STAT3 ao nível do grupo controle e o aumento da expressão de Ca-MKII? na fase herpética. Já na fase pós-herpética, reduziu a fosforilação de JNK e Akt e a expressão de Ca-MKII?, retornou a fosforilação de ERK1,2, PLC?1 e STAT3 ao nível do grupo controle e aumentou a expressão de TRPV1. Nossos resultados indicam que a atividade de PKR desempenha papel essencial na hiperalgesia térmica induzida por infecção pelo HSV1 / Double stranded RNA-activated protein kinase (PKR) is a sentinel molecule activated by cellular stress conditions, including viral infections. PKR activation by phosphorylation triggers cascades involved in inflammatory response and protein synthesis suppression. Our previous data suggest that PKR is involved in the inflammatory thermal hyperalgesia. Here we investigated the role played by PKR on thermal hyperalgesia induced by herpes simplex virus type-1 (HSV-1), during herpetic and post-herpetic phases, by combining behavioral, genetic, pharmacological, and molecular methods. Adult male C57bl/6, PKR+/+ and PKR-/- mice were inoculated with HSV-1. Control groups were inoculated with inactive (mock) HSV1. Mechanical allodynia and thermal hyperalgesia were monitored before virus inoculation and 8, 14, 21, and 28 days post-inoculation. The dose- and timeresponse curve and the capsaicin test were performed at 8th and 21st days post virus inoculation. Also in the herpetic and post-herpetic periods, was investigated the expression profile of proteins involved in the PKR signaling pathways (PKR, eIF2?, PACT, IKK and PP2A?), and the effect of PKR inhibition by monitoring PKR, IKK?/?, P38, JNK, ERK1,2, and STAT3 phosphorylation, and Ca-MKII? and TRPV1 expression in the dorsal root ganglia (L3-L6) ipsilaterally to the inoculated paw. Mechanical allodynia and thermal hyperalgesia became evident until 28 days postinnoculation. PKR-/- mice developed mechanical allodynia but not thermal hyperalgesia, when compared with PKR+/+ mice. Systemic PKR inhibition reversed thermal hyperalgesia in a dose and time-dependent manner, and prevented the capsaicin-induced nocifensive behavior, whereas PKR-/- showed no nocifensive behavior almost absent in both herpetic and post-herpetic phases. There was increased expression of PP2A? and the phosphorylation of PKR, IKK?/?, and eIF2?, during herpetic and post-herpetic periods, and PACT in the post-herpetic phase. PKR inhibition increased P38 phosphorylation in both phases, and reduction of PLC?1 phosphorylation together with the return of the Akt and STAT3 phosphorylation to the control group level, and enhanced Ca-MKII? expression in the herpetic phase. At the post-herpetic phase, suppressed JNK and Akt, and Ca-MKII? expression returned ERK1,2, PLC?1 and STAT3 phosphorylation to control group level and increased TRPV1 expression. The data indicate that PKR activity plays an essential role in the HSV-1 infection-induced thermal hyperalgesia
|
18 |
Rôle des modulateurs de la protéine kinase D dans la propagation du virus herpès simplex de type 1Roussel, Élisabeth 06 1900 (has links)
No description available.
|
19 |
Contribution de la Glycoprotéine M dans la Sortie de HSV-1Zhang, Jie 06 1900 (has links)
Le Virus Herpès Simplex de type 1 (HSV-1) est un agent infectieux qui cause
l’herpès chez une grande proportion de la population mondiale. L’herpès est généralement
considéré comme une maladie bénigne dont la forme la plus commune est l'herpès labial
(communément appelé « bouton de fièvre »), mais elle peut se révéler très sérieuse et causer
la cécité et l’encéphalite, voir létale dans certain cas. Le virus persiste toute la vie dans le
corps de son hôte. Jusqu'à présent, aucun traitement ne peut éliminer le virus et aucun
vaccin n’a été prouvé efficace pour contrôler l’infection herpétique.
HSV-1 est un virus avec un génome d’ADN bicaténaire contenu dans une capside
icosaèdrale entourée d’une enveloppe lipidique. Treize glycoprotéines virales se trouvent
dans cette enveloppe et sont connues ou supposées jouer des rôles distincts dans différentes
étapes du cycle de réplication viral, incluant l'attachement, l'entrée, l’assemblage, et la
propagation des virus. La glycoprotéine M (gM) qui figure parmi ces glycoprotéines
d’enveloppe, est la seule glycoprotéine non essentielle mais est conservée dans toute la
famille herpesviridae. Récemment, l’homologue de gM dans le Pseudorabies virus (PRV),
un autre herpesvirus, a été impliqué dans la phase finale de l’assemblage (i.e.
l’enveloppement cytoplasmique) au niveau du réseau trans-Golgi (TGN) en reconnaissant
spécifiquement des protéines tégumentaires et d’autres glycoprotéines d’enveloppe ([1]).
Toutefois, il a été proposé que cette hypothèse ne s’applique pas pour le HSV-1 ([2]). De
plus, contrairement à la localisation au TGN dans les cellules transfectées, HSV-1 gM se
localise dans la membrane nucléaire et sur les virions périnucléaires durant une infection.
L’objectif du projet présenté ici était d’éclaircir la relation de la localisation et la
fonction de HSV-1 gM dans le contexte d’une infection. Dans les résultats rapportés ici,
nous décrivons tout abord un mécanisme spécifique de ciblage nucléaire de HSV-1 gM. En
phase précoce d’une infection, gM est ciblée à la membrane nucléaire d'une manière virus
ii
dépendante. Cela se produit avant la réorganisation du TGN normalement induite par
l’infection et avant que gM n’entre dans la voie de sécrétion. Ce ciblage nucléaire actif et
spécifique de gM ne semble pas dépendre des plusieurs des partenaires d’interaction
proposés dans la littérature. Ces données suggèrent que la forme nucléaire de gM pourrait
avoir un nouveau rôle indépendant de l’enveloppement final dans le cytoplasme. Dans la
deuxième partie du travail présenté ici, nous avons concentré nos efforts sur le rôle de gM
dans l’assemblage du virus en phase tardive de l’infection et en identifiant un domaine
critique de gM. Nos résultats mettent en valeur l’importance du domaine carboxyl-terminal
cytoplasmique de gM dans le transport de gM du réticulum endoplasmique (RE) à
l’appareil de Golgi, dans l’enveloppement cytoplasmique et la propagation intercellulaire du
virus. Ainsi, l’export du RE de gM a été complètement compromis dans les cellules
transfectées exprimant un mutant de gM dépourvu de sa région C-terminale. La délétion la
queue cytoplasmique de gM cause une réduction légère du titre viral et de la taille des
plaques. L'analyse de ces mutants par microscopie électronique a démontré une
accumulation des nucléocapsides sans enveloppe dans le cytoplasme par rapport aux virus
de type sauvage. Étrangement, ce phénotype était apparent dans les cellules BHK mais
absent dans les cellules 143B, suggérant que la fonction de gM dépende du type cellulaire.
Finalement, le criblage de partenaires d’interaction du domaine C-terminal de gM identifiés
par le système de double-hybride nous a permis de proposer plusieurs candidats
susceptibles de réguler la fonction de gM dans la morphogénèse et la propagation de virus. / Herpes Simplex Virus type 1 (HSV-1) is an infectious agent causing herpes, which
affects a large population worldwide. Herpes is generally considered a benign disease
whose most common form is oral herpes (commonly called "cold sores"), but it can be very
serious and cause herpetic blindness and encephalitis, and even be lethal in some cases. The
virus can persist throughout life in the body of its host. So far, no treatment can eliminate
the virus and no vaccine has proven effective in controlling herpes infections.
HSV-1 has a double-stranded DNA genome embedded in an icosahedral capsid
surrounded by a lipid envelope. Thirteen viral glycoproteins are located in the envelope and
are known or believed to play different roles in different stages of the viral replication cycle,
including attachment, entry, assembly, and viral propagation. Among these envelope
glycoproteins, glycoprotein M (gM) is the only nonessential glycoprotein but is conserved
in all the herpesviridae family. Recently, the homologue of gM in Pseudorabies virus
(PRV), another herpesvirus, has been implicated in the final phase of assembly (e.g. the
cytoplasmic envelopment) at the trans-Golgi network (TGN) ([1]). However, it was
suggested that this does not apply to HSV-1 ([2]). Moreover, unlike its TGN localization in
transfected cells, HSV-1 gM localizes to the nuclear membrane and on the perinuclear
virions during infection.
The objective of the project presented here was to clarify the relationship of the
location and function of HSV-1 gM in the context of an infection. In the results reported
here, we first describe a specific and active mechanism of nuclear targeting of HSV-1 gM. In
early phase of infection, gM is targeted to the nuclear membrane in a virus dependent
manner. This occurs before the known reorganization of the TGN induced by the virus and
before gM enters the secretory pathway. This active and specific nuclear targeting of gM
seemingly does not depend on the functional interaction partners proposed in the literature.
These data suggest that nuclear gM could have a new role independent of that in the final
envelopment in the cytoplasm. In the second part of the work presented here, we focused
iv
our efforts on the role of gM in virus assembly in the late phase of infection and define an
important functional domain within gM. Our results highlight the importance of the
carboxyl-terminal domain of gM in the intracellular transport of gM from endoplasmic
reticulum (ER) to Golgi apparatus, in the cytoplasmic envelopment of the capsids and the
intercellular spread of the virus. Hence, gM ER export was completely compromised in
transfected cells after deletion of its C-terminal tail. Deletion of the gM cytoplasmic tail in
mutant viruses resulted in a slight reduction in viral titer and plaque size. The analysis of
these mutants by electron microscopy showed an accumulation of nucleocapsids without
envelope in the cytoplasm compared to wild-type virus. Interestingly, this phenotype is
apparent in BHK cells but not in 143B cells, hinting that the importance of gM may be cell
type specific. Finally, screening of interaction partners of C-terminal domain of gM
identified by the two-hybrid system allowed us to propose several interesting candidates
that may regulate the function of gM in the virus morphogenesis and propagation.
|
20 |
Atividade da proteína quinase dependente de RNA (PKR) no sistema nociceptivo em um modelo experimental de neuropatia periférica de origem viral / Double stranded RNA-activated protein kinase (PKR) activity in the nociceptive system in an experimental model of peripheral neuropathy of viral originClarissa Maria Dias Mota 25 February 2016 (has links)
A proteína quinase dependente de RNA (PKR) é uma molécula sentinela ativada em situações de estresse celular, incluindo infecções virais. A ativação de PKR por meio de sua fosforilação aciona cascatas de sinalização intracelular envolvidas em respostas inflamatórias e inibição da síntese protéica. Dados prévios do nosso laboratório sugerem que PKR está envolvida na hiperalgesia térmica de origem inflamatória. No presente estudo, foi investigado o papel da PKR na hiperalgesia térmica induzida pelo vírus da herpes simples tipo 1 (HSV1), durante as fases herpética e pós-herpética, combinando métodos comportamentais, genéticos, farmacológicos e moleculares. Camundongos C57bl/6, PKR+/+ e PKR-/- machos foram inoculados com HSV1. Os grupos controle foram inoculados com HSV1 inativo. Alodínia mecânica e hiperalgesia térmica foram monitoradas antes da inoculação do vírus e 8, 14, 21 e 28 dias após a inoculação. A curva dose e temporesposta e o teste da capsaicina foram realizados no 8º e 21º dias após a inoculação do vírus. Também nos períodos herpético e pós-herpético, foi investigado o perfil de expressão de proteínas envolvidas nas vias de sinalização de PKR (PKR, eIF2?, PACT, IKK e PP2A?), assim como o efeito da inibição de PKR pelo monitoramento da fosforilação de PKR, IKK?/?, P38, JNK, ERK1,2 e STAT3, e expressão de CaMKII? e TRPV1 nos GRD (L3-L6) ipsilateralmente à pata inoculada. Alodínia mecânica e hiperalgesia térmica ficaram evidentes até 28 dias após a inoculação. Camundongos PKR-/- desenvolveram alodínia mecânica, mas não hiperalgesia térmica, quando comparados com animais PKR+/+. A inibição sistêmica de PKR reverteu a hiperalgesia térmica de modo tempo- e dose-dependente e preveniu o comportamento nocifensivo induzido por capsaicina, enquanto PKR-/- apresentaram resposta nocifensiva praticamente ausente em ambas as fases herpética e pósherpética. Houve aumento da expressão de PP2A? e da fosforilação de PKR, IKK?/? e eIF2?, durante os períodos herpético e pós-herpético, e de PACT na fase pósherpética. A inibição de PKR promoveu o aumento da fosforilação de P38 em ambas as fases, e redução da fosforilação de PLC?1 acompanhada do retorno da fosforilação de Akt e STAT3 ao nível do grupo controle e o aumento da expressão de Ca-MKII? na fase herpética. Já na fase pós-herpética, reduziu a fosforilação de JNK e Akt e a expressão de Ca-MKII?, retornou a fosforilação de ERK1,2, PLC?1 e STAT3 ao nível do grupo controle e aumentou a expressão de TRPV1. Nossos resultados indicam que a atividade de PKR desempenha papel essencial na hiperalgesia térmica induzida por infecção pelo HSV1 / Double stranded RNA-activated protein kinase (PKR) is a sentinel molecule activated by cellular stress conditions, including viral infections. PKR activation by phosphorylation triggers cascades involved in inflammatory response and protein synthesis suppression. Our previous data suggest that PKR is involved in the inflammatory thermal hyperalgesia. Here we investigated the role played by PKR on thermal hyperalgesia induced by herpes simplex virus type-1 (HSV-1), during herpetic and post-herpetic phases, by combining behavioral, genetic, pharmacological, and molecular methods. Adult male C57bl/6, PKR+/+ and PKR-/- mice were inoculated with HSV-1. Control groups were inoculated with inactive (mock) HSV1. Mechanical allodynia and thermal hyperalgesia were monitored before virus inoculation and 8, 14, 21, and 28 days post-inoculation. The dose- and timeresponse curve and the capsaicin test were performed at 8th and 21st days post virus inoculation. Also in the herpetic and post-herpetic periods, was investigated the expression profile of proteins involved in the PKR signaling pathways (PKR, eIF2?, PACT, IKK and PP2A?), and the effect of PKR inhibition by monitoring PKR, IKK?/?, P38, JNK, ERK1,2, and STAT3 phosphorylation, and Ca-MKII? and TRPV1 expression in the dorsal root ganglia (L3-L6) ipsilaterally to the inoculated paw. Mechanical allodynia and thermal hyperalgesia became evident until 28 days postinnoculation. PKR-/- mice developed mechanical allodynia but not thermal hyperalgesia, when compared with PKR+/+ mice. Systemic PKR inhibition reversed thermal hyperalgesia in a dose and time-dependent manner, and prevented the capsaicin-induced nocifensive behavior, whereas PKR-/- showed no nocifensive behavior almost absent in both herpetic and post-herpetic phases. There was increased expression of PP2A? and the phosphorylation of PKR, IKK?/?, and eIF2?, during herpetic and post-herpetic periods, and PACT in the post-herpetic phase. PKR inhibition increased P38 phosphorylation in both phases, and reduction of PLC?1 phosphorylation together with the return of the Akt and STAT3 phosphorylation to the control group level, and enhanced Ca-MKII? expression in the herpetic phase. At the post-herpetic phase, suppressed JNK and Akt, and Ca-MKII? expression returned ERK1,2, PLC?1 and STAT3 phosphorylation to control group level and increased TRPV1 expression. The data indicate that PKR activity plays an essential role in the HSV-1 infection-induced thermal hyperalgesia
|
Page generated in 0.0975 seconds